Determination of mutation patterns in human ornithine transcarbamylase precursor.

作者: Shaomin Yan , Guang Wu

DOI: 10.1007/S10877-009-9162-3

关键词:

摘要: Objective. The ornithine transcarbamylase is a mitochondrial matrix homotrimeric enzyme, whose deficiency the most common genetic defect of urea cycle and an X-linked semidominant disorder. To understand its mutation pattern very helpful for managing clinical manifest outcome. Methods. amino-acid pair predictability used to transfer symbolized human 117 missense point mutants scalar data classify pairs as predictable unpredictable in order that we can analyse domain rather than symbol domain. Results. results show highly likely occur at pairs, has trend make approach predictable. Conclusion. provide insight on from viewpoint based random mechanism.

参考文章(37)
Katharina Engel, Jean-Marc Nuoffer, Chris Mühlhausen, Vera Klaus, Carlo R. Largiadèr, Konstantinos Tsiakas, René Santer, Bendicht Wermuth, Johannes Häberle, Analysis of mRNA transcripts improves the success rate of molecular genetic testing in OTC deficiency Molecular Genetics and Metabolism. ,vol. 94, pp. 292- 297 ,(2008) , 10.1016/J.YMGME.2008.03.009
Wendy Smith, Priya S. Kishnani, Brendan Lee, Rani H. Singh, William J. Rhead, Lisa Sniderman King, Michael Smith, Marshall Summar, Urea Cycle Disorders: Clinical Presentation Outside the Newborn Period Critical Care Clinics. ,vol. 21, ,(2005) , 10.1016/J.CCC.2005.05.007
Beth A. McCullough, Marc Yudkoff, Mark L. Batshaw, James M. Wilson, Steven E. Raper, Mendel Tuchman, Genotype spectrum of ornithine transcarbamylase deficiency: correlation with the clinical and biochemical phenotype. American Journal of Medical Genetics. ,vol. 93, pp. 313- 319 ,(2000) , 10.1002/1096-8628(20000814)93:4<313::AID-AJMG11>3.0.CO;2-M
Mendel Tuchman, Brendan Lee, Uta Lichter-Konecki, Marshall L. Summar, Marc Yudkoff, Stephen D. Cederbaum, Douglas S. Kerr, George A. Diaz, Margaretta R. Seashore, Hye-Seung Lee, Robert J. McCarter, Jeffrey P. Krischer, Mark L. Batshaw, Cross-sectional multicenter study of patients with urea cycle disorders in the United States. Molecular Genetics and Metabolism. ,vol. 94, pp. 397- 402 ,(2008) , 10.1016/J.YMGME.2008.05.004
G. Suriano, L. Azevedo, M. Novais, B. Boscolo, R. Seruca, A. Amorim, E. M. Ghibaudi, In vitro demonstration of intra-locus compensation using the ornithine transcarbamylase protein as model Human Molecular Genetics. ,vol. 16, pp. 2209- 2214 ,(2007) , 10.1093/HMG/DDM172
Manel Camps, Asael Herman, Ern Loh, Lawrence A. Loeb, Genetic constraints on protein evolution. Critical Reviews in Biochemistry and Molecular Biology. ,vol. 42, pp. 313- 326 ,(2007) , 10.1080/10409230701597642
Neil Gordon, Ornithine transcarbamylase deficiency: a urea cycle defect. European Journal of Paediatric Neurology. ,vol. 7, pp. 115- 121 ,(2003) , 10.1016/S1090-3798(03)00040-0
Christian Jäckel, Peter Kast, Donald Hilvert, Protein Design by Directed Evolution Annual Review of Biophysics. ,vol. 37, pp. 153- 173 ,(2008) , 10.1146/ANNUREV.BIOPHYS.37.032807.125832
Bridget Wilcken, Problems in the management of urea cycle disorders Molecular Genetics and Metabolism. ,vol. 81, pp. 86- 91 ,(2004) , 10.1016/J.YMGME.2003.10.016
J E Wraith, Current topic: Ornithine carbamoyltransferase deficiency Archives of Disease in Childhood. ,vol. 84, pp. 84- 88 ,(2001) , 10.1136/ADC.84.1.84